U.S. Markets close in 1 hr 49 mins

Zacks.com featured highlights: Amarin, Compugen, Raptor Pharmaceuticals, ArcelorMittal and Hovnanian Enterprises

Zacks Equity Research

For Immediate Release

Chicago, IL – September 07, 2016 - Stocks in this week’s article include: Amarin Corp. (AMRN), Compugen (CGEN), Raptor Pharmaceuticals (RPTP), ArcelorMittal ( MT) and Hovnanian Enterprises (HOV).

Screen of the Week of Zacks Investment Research:

Explosive Stocks Under $10

This screen is a bit of a departure from my normal stock screens.

Usually I require my screens to have a minimum price of $10 per share.

But I do at times scan for stocks under $10. And that's one of the screens I'm running for myself right now.

Penny Stocks

One dollar is a common threshold when screening for stocks. A lot of investors actively avoid penny stocks due to the speculative nature, the often wide bid/ask spreads, and the excessive volatility that is all too common in stocks under $1.00.

But some, of course, work out spectacularly well. And that's probably what keeps people interested in them.

Seeing a stock make a 100% return or 200% return or more from a base of 50 cents, for example, seems easier than investing in a $50 stock or $100 stock and seeing that double or triple.

$5 Stocks

Five dollars is another common minimum when screening for stocks since many institutional investors won't even consider a stock if it's trading under $5. And since institutional investors are usually the ones that can move a stock; having stocks that are open to them is usually a bonus.

And quite frankly, lots of cheap stocks are cheap for a reason, i.e., that's all they're worth.

But being over $5 does put them into a different category of consideration. Maybe not the best category, but a step up from stocks less than a dollar.

Stocks Under $10

My minimum has typically been $10. With over 10,000 stocks out there, this minimum quickly lets me cull down several thousand stocks with a click of a button.

That doesn't mean there aren't any good stocks below that price point, because there are.

And I can recall several sub-$10 stocks in the past that worked out exceptionally well. Maybe it's because I use them sparingly. Or maybe it's because I'm ultra picky in selecting them.

Either way, there can be a place for cheaper stocks in your portfolio sometimes.

And that's what we're looking at today.

Screen Parameters

Price less than or equal to $10

Average Dollar Volume greater than or equal to $1,000,000
(Price x volume shows you how much money is trading in and out of the stock on a daily basis.)

Weekly Volume greater than Previous Week's Volume (any two out of three weeks)
(Want to see increasing volume to show greater investor interest and demand.)

Zacks Rank less than or equal to 3
(No Sells or Strong Sells.)

Average Broker Rating less than or equal to 3.5
(Average Broker Rating of a Hold or Better.)

# of Analysts in Rating greater than or equal to 2
(Minimum of at least two analysts covering the stock.)

% Change F1 Earnings Estimate Revisions -- 12 Weeks greater than or equal to 0
(Preferably upward earnings estimate revisions, but definitely no downward revisions.)

Stocks

Here are 5 stocks that made it through this week's screen:

(AMRN) Amarin Corp.
(CGEN) Compugen
(RPTP) Raptor Pharmaceuticals
(MT) ArcelorMittal
(HOV) Hovnanian Enterprises

I think each one of these picks has big potential. And the entire list is worth a thorough analysis.

I would not suggest filling up an entire portfolio of stocks under $10 though. But adding a careful selection of some of the best cheap stock names could add some excess returns to your bottom line, not to mention a little excitement to your stock picking process as well.

Get the rest of the stocks on this list and start screening for the best stocks under $10 for yourself. And don't forget to backtest your strategy so you'll know how successful it's been before you put any of your money at risk. You can do it.

Sign up for a free two week trial to the Research Wizard today.

Want more articles from this author? Scroll up to the top of this article and click the FOLLOW AUTHOR button to get an email each time a new article is published.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.

Zacks Restaurant Recommendations: In addition to dining at these special places, you can feast on their stock shares. A Zacks Special Report spotlights 5 recent IPOs to watch plus 2 stocks that offer immediate promise in a booming sector. Download it free »

Sign up now for your free trial today and start picking better stocks immediately. And with the backtesting feature, you can test your ideas to see how you can improve your trading in both up markets and down markets. Don’t wait for the market to get better before you decide to do better. Start learning how to be a better trader today: https://at.zacks.com/?id=111

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Each week, Zacks Profit from the Pros free email newsletter shares a new screening strategy. Learn more about it here https://at.zacks.com/?id=112

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros.

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com

Visit: https://www.zacks.com/performance

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer .

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AMARIN CORP PLC (AMRN): Free Stock Analysis Report
 
COMPUGEN LTD (CGEN): Free Stock Analysis Report
 
RAPTOR PHARMACT (RPTP): Free Stock Analysis Report
 
ARCELOR MITTAL (MT): Free Stock Analysis Report
 
HOVNANIAN ENTRP (HOV): Free Stock Analysis Report
 
To read this article on Zacks.com click here.